serplulimab
fosun pharmaceuticals
['lcsm,(-blcsm)', 'serplulimab', 'sclc']
serplulimab, first anti-pd1 to demonstrate os gain in combination with chemo in 1l ed-sclc in asian population. resembles anti-pdl1 approved icis: separation of os curves after induction. remarkable 15.6m mos #asco22 #lcsm 
Medical Oncology ?? HGU Gregorio Marañón?@myESMO Faculty ?? Lung Cancer - Mesothelioma - Thymoma?Power to the patients #endlungcancer #lcsm